Skip to main navigation
Skip to search
Skip to main content
Fox Chase Cancer Center Home
Help & FAQ
Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
BCR-ABL1 kinase: Hunting an elusive target with new weapons
Tomasz Skorski
Nuclear Dynamics and Cancer (NDC)
Center for Immunology
Temple University
Research output
:
Contribution to journal
›
Short survey
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'BCR-ABL1 kinase: Hunting an elusive target with new weapons'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
100%
Protein Tyrosine Kinase Inhibitor
25%
Imatinib
25%
Dasatinib
25%
Adenosine Triphosphate
25%
Nilotinib
25%